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Abstract
Purpose: To describe the methods used to identify and validate congenital malformation
diagnoses recorded in UK electronic health records, and the results of validation studies.
Methods: Medline and Embase were searched for publications between 1987 and
2019 that involved identifying congenital malformations from UK electronic health
records using diagnostic codes. The methods and code-lists used to identify congeni-
tal malformations, and the methods and results of validations, were examined.
Results: We retrieved 54 eligible studies; 36 identified congenital malformations from
primary care data and 18 from secondary care data alone or in combination with birth
and/or death records. Identification in secondary care data relied on codes from the ‘Q’
chapter for congenital malformations in ICD-10. In contrast, studies using primary care
data frequently used additional codes outside of the ‘P’ chapter for congenital malforma-
tion diagnoses in Read, although the exact codes used were not always clear. Eight stud-
ies validated diagnoses identified in primary care data. The positive predictive value was
highest (80%–100%) for congenital malformations overall, major malformations, and
heart defects although the validity of the reference standard used was often uncertain. It
was lowest for neural tube defects (71%) and developmental hip dysplasia (56%).
Conclusions: Studies identifying congenital malformations from primary care data
provided limited details about the methods used. The few validation studies were
limited to diagnoses recorded in primary care. Further assessments of all measures of
validity in both data sources and of other malformation subgroups are needed, using
robust reference standards and adhering to reporting guidelines.
K E YWORD S
congenital abnormalities, electronic health records, pharmacoepidemiology, systematic
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1 | INTRODUCTION
Large databases of anonymised, routinely collected electronic health
records (EHR) are increasingly being used for post-licensure safety stud-
ies of drugs and vaccines given in pregnancy.1,2 UK primary care data-
bases, such as the Clinical Practice Research Datalink (CPRD), contain
information recorded in general practice for a representative sample of
the population.3 Secondary care databases, such as Hospital Episode Sta-
tistics Admitted Patient Care (HES-APC), capture information on all
patients admitted to NHS hospitals in England.4 These and other admin-
istrative data such as death certificates can be provided to researchers
pre-linked to maximise the ascertainment of safety outcomes.3,4
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Congenital malformations (CMs) are rare but important outcomes
in safety studies. Therefore, the methods used to identify CMs in EHR
are of interest. In primary care, clinical data including diagnoses and
procedures are currently coded using the hierarchical Read coding
system; some practices previously used Oxford Medical Information
System (OXMIS) codes.3 In secondary care, diagnoses and procedures
are coded using the International Classification of Diseases 10th Revi-
sion (ICD-10) and the Classification of Interventions and Procedures
4th Revision (OPCS-4), respectively.4 Death certificates are also
coded using ICD-10.5 By developing a list of relevant codes (‘code-
lists’) researchers can search patient records in EHR data to identify
CM diagnoses.6
Chapters ‘P’ in Read and ‘Q’ in ICD-10 are dedicated to CM
codes. However, clinical coders may use codes from other chapters to
record CMs. For example, congenital pulmonary valve malformations
could be recorded using the Read code ‘pulmonary valve anomalies’
from the CM ‘P’ chapter or the less specific Read code ‘pulmonary
valve disorders’ from the ‘G’ chapter on circulatory system diseases.
Inclusion of broad-ranging codes from outside dedicated CM chapters
enables more complete capture of CMs but also increases the risk of
capturing non-congenital conditions.
To aid code-list development, researchers can refer to publi-
shed guidelines which define codes for particular conditions or pro-
vide relevant key terms which can be used to identify equivalent
codes. The ‘European Surveillance of Congenital Anomalies’ net-
work (EUROCAT), for example, publishes the modified ICD-10
codes used by registries to code and classify CMs identified in the
first year of life.7 However, such guidelines are not used to encode
CMs in routine clinical practice.
The heterogeneity of CMs and lack of a standardised algorithm
for their identification in EHR complicate their ascertainment and may
result in a variety of approaches, affecting replicability across studies
and validity of the findings. Previous reviews have noted the good
validity of diagnostic codes in UK EHR overall.8,9 However, to date,
no study has systematically assessed the validity of code-lists devel-
oped to identify CMs in these data.
This systematic review aimed to inform future safety studies by
describing the methods used to identify individuals with CMs from
UK EHR and by summarising the results of associated validations.
2 | METHODS
We carried out a systematic review of studies that involved identify-
ing CMs in UK EHR. The systematic review was registered with
PROSPERO (registration number: CRD42017037168).
2.1 | Eligibility criteria
Studies were included if they used diagnostic codes to identify CMs in
UK EHR and were published after 1987 (the year CPRD was
established).3 As our main objective was to review the methods used
to identify CMs from large electronic datasets, case series and case
reports were excluded. We further excluded: studies of populations
sourced solely from tertiary care settings or specialist registries as
we considered the differences in casemix and coding practices in
these settings would limit the generalisability of results; studies
restricted to CMs that are frequently excluded from safety studies
(e.g., chromosomal abnormalities); conference abstracts due to insuf-
ficient methodological detail to meet the objectives of this review.
Validations of diagnostic codes for CMs, reported within the
EHR studies identified, were included if they used either of the fol-
lowing methods: (1) comparison of individual diagnoses to a refer-
ence standard such as an external database, anonymised free-text
(entered by the GP alongside electronic coding), additional informa-
tion from GPs via questionnaires, or provision of anonymised paper
records such as hospital letters, or (2) comparison of prevalence
rates with rates derived from external population-based data. Vali-
dation studies of individual diagnoses had to report ≥1 validity
measurement (sensitivity, specificity, positive predictive value
(PPV) or negative predictive value (NPV)), or provide data that
allowed their calculation.
2.2 | Search strategy and study selection
Medline and Embase were searched up to 20 September 2019 for
English-language publications using a wide-ranging search strategy
that included keywords and subject headings for ‘congenital mal-
formations’ and ‘electronic health records’ (Supporting Information
Methods). This was supplemented with a manual search of the bibli-
ographies of three of the main UK primary care EHR databases
(CPRD, The Health Improvement Network [THIN] and QResearch)
and the Boston Collaborative Drug Surveillance Programme.10-13 Ref-
erence lists of relevant reviews and eligible studies were also
searched.
Key Points
• Post-licensure safety studies of drugs and vaccines in
pregnancy have relied on primary care data.
• More extensive use of linked data, such as linked primary
and secondary care data, would allow fuller ascertain-
ment of malformations.
• The positive predictive value for congenital mal-
formations overall, major malformations and heart
defects is high (80%–100%) in primary care data.
• Further validation studies are needed of other congenital
malformation subgroups in primary care data and in sec-
ondary care data.
• There is a need for fuller reporting of the methods and
code-lists used to identify congenital malformations in
studies using electronic health records.
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The titles and abstracts of studies identified in the search were
screened by MP to determine eligibility for full-text review. A sample
of abstracts were also screened by ST and PM to establish consis-
tency, with any differences resolved through discussion.
2.3 | Data extraction
Using a standardised form, details of the methods used to identify
CMs were extracted from each study, including the specific CMs
identified with any exclusions or subsequent classification into sub-
groups, any externally developed guidelines used to inform case def-
initions, and details of the identification process (any code-lists or
methods used to develop them, and whether a computerised search
using code-lists was conducted versus manual review of records to
identify possible malformations). Code-lists not included in publica-
tions but publicly available elsewhere were identified or requested
from authors.
When studies examined the diagnostic validity of recorded CMs,
we extracted data on: the main conditions validated, the proportion of
identified diagnoses that authors chose to validate and the rationale
for their selection, the reference standard used, the response rate for
any information requests and the reasons for non-responses, and the
reported results. When validation comprised prevalence comparisons
with external data-sources, we extracted information about the exter-
nal data-source, the period of comparison and the results.
2.4 | Quality assessment
A modified version of the Quality Assessment of Diagnostic Studies
tool (QUADAS-2) was used to assess the quality of validation stud-
ies.14 Six areas from the tool applicable to EHR were adapted for use:
enrolment of patients, patient exclusions, blinding to the reference
standard results, the validity of the reference standard, consistent use
of the reference standard, and inclusion of patients in the analysis
(Table S1).
2.5 | Data synthesis and analysis
Studies were stratified by healthcare setting (primary or secondary
care) and then by type of CM. The methods used to identify CMs,
and the methods and results of validation studies, were summarised
for each stratum. When studies presented validation measures
without 95% confidence intervals (CIs), these were calculated using
the Wilson method. As there were very few validation studies
within strata, with diverse methodologies, formal assessment of
between-study heterogeneity and summary estimates of validation
measures were not attempted.15 Instead, heterogeneity in validity
estimates within strata was investigated using χ2 tests, using the
same approach as that in a recent systematic review of dementia
diagnoses in UK EHR.16
3 | RESULTS
We retrieved 54 eligible studies that identified CMs from UK EHR
(Figure 1). Thirty-six identified CMs from primary care data, with most
assessing drug safety during pregnancy. The majority used stand-
alone CPRD (n = 21) and examined all major malformations
(n = 19).17-52 One study also used linked HES data for validation (dis-
cussed further below).52
The remaining 18 studies identified CMs from secondary care
data, with most assessing health service delivery, surgical outcomes or
disease trends.53-70 Almost all used HES (n = 16) and the most com-
monly identified CMs were heart (n = 4) and orofacial defects (n = 4).
Eight studies also used linked (n = 6)53-57,67 or unlinked (n = 1)58
death records and/or linked birth data (n = 2).67,68
3.1 | Identifying malformations in primary
care data
Published guidelines were often used in the 36 primary care studies
to develop case definitions for CMs and any anatomical subgroups
(Table 1). Of the 22 studies that identified ‘any’ or ‘major’ mal-
formations, 91% (n = 20) consulted guidelines, with most using
EUROCAT (n = 16).17,19-32,36 Four studies indicated that they also
sought clinical input alongside the guidelines (Table 1).19-21,48
Once defined, the methods used to identify CMs of interest from
EHR were rarely specified. Twenty-three studies were known to have
used Read and/or OXMIS code-lists because these were publicly avail-
able (n = 11)25-32,36,49,52 or could be obtained from authors
(n = 12)23,24,33-35,37,38,40,43,48,50,51 and a further three studies were con-
sidered likely to have used code-lists based on their content and commu-
nication with authors (Table 2).39,45,46 Of these, only three specified using
computerised searches to apply their code-lists to the data.33-35 Two
studies did not use a code-list but manually reviewed electronic
records.19,22 For the remaining eight studies, the use of a code-list was
uncertain.17,18,20,21,41,42,44,47 Among all 36 studies, three also described
examining anonymised free-text in maternal records to identify evidence
of CMs among pregnancy losses and/or terminations (Table 1).18,22,23
Code-list development was described briefly in 17 studies
(Table 1). Most relied on relating relevant ICD codes, often deter-
mined using published guidelines such as EUROCAT, to equivalent
Read/OXMIS codes (n = 16; Table 1).23-35,37,38,48 However, only
three studies described how this was achieved:23,24,48 by creating text
search terms using ICD code descriptions and applying these to Read/
OXMIS dictionaries to identify relevant codes23,24 or by examining all
Read/OXMIS codes in patients' records and including those thought
to correspond to relevant ICD codes.48
We examined the codes used to identify CMs in the 24 studies
that definitely or probably used Read code-lists.23-36,39,40,43,45,46,48-52
For 16 of these, only broad initial code-lists were available, including
codes that were not part of the final CM case definition
(Table 2).23-36,40,48 Another three only provided the subset of codes
identified in the study population rather than all codes used to search
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records.39,45,46 Specific, detailed code-lists were available for just five
studies (Table 2).43,49-52
All 24 studies considered ‘P’ chapter Read codes when identifying
CMs. Although rarely detailed in the published methods, most also con-
sidered to a varying extent codes from other chapters (Table 2). Most
frequently considered were codes related to procedures (n = 20; e.g.,
‘repair of cleft lip operations’) and diagnoses (n = 19; e.g., ‘mitral steno-
sis’ from the ‘G’ chapter on circulatory system diseases; Table 2). Stud-
ies also frequently considered codes indicating a personal history of
CMs (n = 14), and administrative codes for care transfers, monitoring
or counselling of individuals with CMs (n = 12; e.g., ‘transfer of care
from paediatric congenital heart services’). Codes relating to testing or
screening for CMs (e.g., ‘screening for congenital eye anomaly’) or con-
ditions identified on examination (e.g., ‘observed on examination—
pigeon chest’) were least frequent (n = 2).
3.2 | Identifying malformations in secondary
care data
All 18 studies identifying CMs in secondary care and/or birth and death
certificate data used publicly available code-lists, although none
specified whether computerised or manual searches were carried out
(Table 3). All ICD-10 codes were from the ‘Q’ chapter for CMs. Half of
the studies also used OPCS-4 codes, often because procedures were
relevant to the study question. The methods used to develop ICD-10
code-lists were publicly available for six studies which examined CMs
as a subset of chronic or life-limiting conditions.53,54,67-70 The methods
described were therefore not specific to CMs although two studies did
use EUROCAT guidelines to define and identify these.53,54
3.3 | Validation of codes used to record
malformations in primary care
Eight studies validated CMs identified in primary care data by estimat-
ing the PPV of coded diagnoses (Table 4).17,22,24,38,39,46,49,52 Although
all studies examined postnatal diagnoses, only two of these included
CMs identified in the antenatal period from maternal records (one of
which estimated separate PPVs for postnatal and antenatal diagno-
ses). One study used linked HES data as the reference standard to
validate CMs identified in CPRD, but most relied exclusively on GP
questionnaires (n = 4) or further primary care data including
anonymised free-text and complete paper records (n = 3).
F IGURE 1 Identification of
eligible studies


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































892 PEPPA ET AL.
Although the quality of most studies was assessed as good, the
validity of the reference standards was often uncertain as details of
the type of information used by GPs to confirm diagnoses
(e.g., hospital letters) were seldom described (Table 5; Table S2). The
length of time either side of the recorded diagnosis date during which
supportive evidence was sought was also seldom reported; just one
study described searching for all types of supportive evidence within
a defined time window for all potential cases (Table 4).52 Studies also
differed in the methods used to calculate PPV; some calculated a con-
servative PPV by including in the denominator the total number of
individuals for whom information was requested whilst others
included only those for whom requested information was returned.
Estimates of PPV were generally high (Figure 2). The one study of any
CM (major or minor) reported a PPV of 81%17 and three studies examining
major malformations reported estimates from 85% to 100% with no evi-
denceofbetween-studyheterogeneity (n= 3; χ2 test=2.7;p= 0.3).22,24,38
However, one studydemonstrated that thePPVvariedaccording to the ref-
erence standard used, being lower when validated against free-text review
compared to complete paper record review (78% vs. 92%, χ2 test = 7.2;
p = 0.007).24 Similarly, both studies of heart defects reported PPVs ≥90%
(withthe lowest lowerconfidence limitbeing81%).46,49
Estimates of PPV were lower for neural tube defects, the majority
of which were identified antenatally from maternal records; overall PPV
was 71% and was similar for antenatal and postnatal diagnoses (69%
vs. 75%). The PPV varied from 47% to 83% for neural tube defect sub-
types.39 Only 34% of patients with a developmental hip dysplasia diag-
nosis in CPRD also had specific evidence of a diagnosis or procedure in
HES in-patient data within 2 years, increasing to 56% when less spe-
cific supportive evidence was considered.52 The reference standard in
this study was, however, considered suboptimal (Table S2).
Validation based on comparing prevalence in primary care data
with external data-sources suggested prevalence was comparable to
or higher than in national or regional population-based registries (-
Table S3). Between 1990 and 2009, the prevalence ratio between
THIN and UK EUROCAT data for major CMs diagnosed in the first year
of life and defined according to EUROCAT guidelines was 1.18 (95%CI,
1.16–1.20)31 and for heart defects was 1.31 (95%CI, 1.26–1.35). Preva-
lence was comparable for nervous system malformations (PR = 1.06;
95%CI, 0.98–1.14). Similar results were seen in studies comparing the
prevalence of such conditions in the first year of life in CPRD with
population-based registries.39,48 Compared to EUROCAT, THIN
appeared to under-ascertain urinary, orofacial, digestive and abdominal
malformations, and rare conditions such as Ebstein's anomaly.31 How-
ever, the prevalence of conditions increased in both THIN and CPRD
when follow-up was extended beyond the first birthday.31,48
3.4 | Validation of codes used to record
malformations in secondary care and other UK EHR
No formal validation studies of CM diagnoses identified in secondary care
data were retrieved, although some authors described evidence
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2009, 85% of almost 9000 individuals identified from a UK orofacial cleft
registry could be linked to HES, with >92% concordance of diagno-
ses.59-62 Another study noted 98% concordance between a specialist sur-
gical database for developmental hip dysplasia and surgical interventions
for this condition in Scottish admissions data.63
One study identified deceased infants with a life-limiting CM
recorded in in-patient HES data (n = 6823) or linked Scottish birth
and in-patient data (n = 555).67 Completeness of recording of the CM
in death certificates was 80% and 89%, respectively.
4 | DISCUSSION
We retrieved 54 studies, 36 of which used UK primary care data and
18 of which used UK secondary care data (sometimes supplemented
with birth or death records) to identify CMs. Completeness of
reporting and methodologies differed between these two subgroups.
Primary care studies frequently used published guidelines to develop
case definitions and Read code-lists for CMs of interest. Code-lists
were not always publicly available; those that were demonstrated that
although the Read system ‘P’ chapter is dedicated to CM diagnoses,
codes from other diagnostic chapters and codes for procedures, medi-
cal histories or administrative tasks were also used to a varying extent,
usually without describing the criteria for their inclusion.
In contrast, all secondary care studies made the diagnostic codes
used to identify CMs publicly available, but few described using publi-
shed guidelines to inform case definitions and code-lists. All studies
restricted ICD-10 diagnostic codes to the CM ‘Q’ chapter, with half
also using OPCS-4 procedure codes. Clinical coders in hospital set-
tings, unlike primary care, are required to encode definitive diagnoses
for reimbursement purposes.4 This could explain why researchers
relied on ‘Q’ chapter CM codes in these data, but considered Read
codes beyond the ‘P’ chapter in primary care data.
We identified only eight validation studies. All CM diagnoses
undergoing validation were identified from primary care data and all
studies assessed PPV. No validation studies of CMs identified from
secondary care data were retrieved and no study linked to secondary
care data for the purpose of assessing completeness of recording of
CMs in primary care records. Although Read code-lists for CMs varied
across studies, few examined the validity of individual codes and none
considered the validity of ‘P’ chapter versus non-‘P’ chapter codes.
Just three malformation subgroups were validated, with insufficient
F IGURE 2 Individual-study estimates for PPV of congenital malformations in primary care data. aIncluded conditions that could potentially be
classified as major under certain criteria. bSpecific diagnostic or procedural codes in HES. cSearched for specific diagnostic/procedural codes or
codes that were likely to relate to developmental hip dysplasia (e.g., ‘clicking hip’). dSearched for specific or related codes or evidence of a
hospital admission within 6 months of the diagnosis in the primary care record. eSearched for any evidence in HES (as defined previously) or
supportive evidence anywhere in the electronic primary care record such as multiple records of the diagnosis, regular orthopaedic hospital
attendances etc. Abbreviations: A, anencephaly; CI, confidence interval; COA, coarctation of aorta; DDH, developmental hip dysplasia; E,
encephalocele; GP, general practitioner; HES, hospital episode statistics; M, meningocele; MCM, major congenital malformation; NTD, neural tube
defects; PPV, positive predictive value; SB, spina bifida; TOF, tetralogy of fallot; VSD, ventricular septal defect
894 PEPPA ET AL.
studies to obtain robust PPV summary estimates. The PPV was high
for CMs overall, for major CMs, and for heart defects, ranging from
80% to 100%.17,23,24,38,46,49 These estimates are in line with previous
findings of a median PPV of 89% for 183 different diagnoses in
CPRD.8 The overall PPV for neural tube defects was slightly lower,
and for developmental hip dysplasia was markedly lower, at 56%.39,52
These PPV results should be interpreted with caution. Validation
studies assume that the reference standard has perfect sensitivity and
specificity for the diagnosis of interest. However, the robustness of the
reference standard was considered uncertain in six of the eight validation
studies.17,22,24,38,39,49 Studies using GP questionnaires, anonymised free-
text or anonymised paper records as the reference rarely described what
information was considered sufficient to confirm diagnoses, and this may
have varied across studies and reference sources. Indeed, one study esti-
mated a lower PPV using free-text review compared to paper record
review; free-text may less completely capture evidence for CMs and thus
underestimate PPV. Use of a different EHR dataset as the reference stan-
dard may also be imperfect. Using in-patient HES as the reference, the
PPV for hip dysplasia recorded in CPRD was low.39,52 This may be
explained by the inclusion of CPRD diagnoses made before the earliest
available HES data, and those treated with non-surgical interventions,
which would not be captured in in-patient data.73
Estimates of diagnostic validity may also depend on the severity
of the CM and the length of the time window chosen to search for
supportive evidence. Major CMs with severe phenotypes requiring
intensive clinical management are more likely to be encoded in the
patient record than CMs with milder phenotypes, potentially increas-
ing both sensitivity estimates for EHR diagnoses and their PPV (due
to higher levels of diagnostic recording in the reference data source).
Searches for supportive evidence conducted over longer periods
(e.g., throughout childhood) may also yield higher PPVs than shorter
searches (e.g., in the year after initial diagnosis), particularly for milder
phenotypes where clinical contact is infrequent. Validation studies
rarely defined the length of time used for these searches, however,
and so the potential impact of this on PPV was uncertain.
There may also be genuine differences in the PPV among sub-
populations assessed using different reference standards. Full paper
records may not be provided if the patient has died or left the practice, or
has extensive case notes that are time-consuming for practices to process.
Such patients could have a higher or lower probability of a genuine CM
compared to those with available paper records. Other concerns include
differences across studies in the denominators used to calculate PPV, and
studies conducted over different time periods. PPV varies with the preva-
lence of the condition in the population, and prevalence of some CMs
may have changed over time, for example, due to increased ascertainment
following improved screening methods. PPV estimates obtained in older
studies may not therefore be generalisable to current data.
Finally, although some CMs are detected antenatally and are
associated with pregnancy outcomes such as terminations, validation
studies focused heavily on postnatal diagnoses. GPs are often the first
health professional seen by pregnant women but most antenatal
checks do not occur in the GP surgery and so antenatal diagnoses of
CMs in primary care data may be incompletely captured.74
Furthermore, pregnancy outcomes such as terminations have been
shown to be under-recorded in these data.75 This may explain why
studies rarely examined antenatal diagnoses. A further challenge is
distinguishing whether antenatally recorded CMs relate to the mother
or offspring. The validation study of neural tube defects found that
37% of antenatally recorded spina bifida diagnoses related to the
mother, not the offspring, lowering the overall PPV for neural tube
defects.37
The prevalence of CMs identified in the first year of life from primary
care databases was comparable to or higher than in registries and
increased with longer follow-up.31,39,48 This could reflect limited follow-
up and voluntary notification systems for some registries.7,76 Higher prev-
alence in primary care data may also reflect imperfect PPV for CM codes.
Using Read codes from outside the ‘P’ chapter may increase the ascer-
tainment of CMs but decrease the PPV if these codes are also used to
record non-congenital conditions. The influence of the codes used is also
pertinent to studies of secondary care data. A very recent study, publi-
shed after we completed the search for this review, identified CMs in UK
hospitalisation data using three different ICD-10 code-lists.77 The preva-
lence of CMs was shown to depend markedly on the code-list applied,
ranging from 1.8% to 4.1%.77
4.1 | Strengths and limitations
To our knowledge, our study is the first to examine systematically the
methods used by researchers to identify individuals with CMs
recorded in UK EHR and the results of associated validation studies.
Our comprehensive search strategy is likely to have captured the
majority of relevant studies. Our review also brings together the ICD-
10 code-lists used to identify CMs in secondary care data. The Read
code-lists used in primary care studies were not all publicly available,
but our efforts to contact authors enabled us to obtain additional lists.
Our findings have some limitations. First, it was not possible to
obtain detailed Read code-lists for all the studies of primary care data.
Available code-lists were often broad in nature and included codes
that were not part of the final case definition. Therefore, our summary
of the Read codes used to identify CMs was incomplete and it was
unclear in some studies which codes were ultimately used.
In addition, the small number of validation studies identified were
insufficient to allow formal assessment of the risk of publication bias
in this review. Validations of diagnoses in EHR are often a minor com-
ponent of the main study. Finally, validations estimating low PPV
could be less likely to be included in publications than those estimat-
ing higher PPV. If so, the PPVs reported in this review may be a biased
subset of the PPVs that have been carried out.
5 | CONCLUSIONS AND
RECOMMENDATIONS
This review provides a detailed summary of the methods and code-
lists used to identify CMs from UK EHR, which will help guide future
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safety studies. It has highlighted the need to increase the methodolog-
ical detail provided by such studies and the sharing of Read code-lists,
in line with the 2015 reporting guidelines for studies using observa-
tional routinely collected health data.78
Further validation studies are also needed for a range of malfor-
mation subgroups, and estimating all measures of validity (sensitivity,
specificity and NPV). Validation of diagnoses in hospital data are
required to address information gaps and to assess the robustness of
studies using these data. In addition, UK general practices are cur-
rently switching from use of Read codes to the SNOMED coding sys-
tem.79 Work will therefore be needed to assess the validity of
equivalent SNOMED codes to those currently used for CMs.
Finally, more extensive use of linked primary and secondary care data
could enable an understanding of the completeness of each data source for
different CMs and allow for fuller ascertainment of these conditions. The
gradual increase in theelectronic recordingof codeddiagnoses in linkedout-
patient hospital data will enable their future use in malformation research,
improvingascertainmentof thosewhodonot require in-patient care.
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